All News

Preventive drugs are frequently continued in patients with cancer near end of life despite limited clinical benefit.

Study finds older patients administered combined immunosuppression experienced similar remission of Crohn disease as those aged under 60 years.

Top news of the day from across the health care industry.

Although generic versions of prescription medications can be a cheaper alternative for patients, many perceive generics as less effective and less safe than their brand-name counterparts.

Achievable steps could be taken to reach the World Health Organization goal of eliminating hepatitis B and C virus infections as public health threats by 2030.

Bayer Healthcare and Janssen Pharmaceuticals Inc., the makers of the Xarelto® (rivaroxaban), agreed to resolve approximately 25,000 state and federal claims about the drug with payment.

The findings could help promote interventions aimed at improving patient and provider confidence in generic drugs for managing chronic diseases.

Study is the first and largest of its kind to examine mortality associated with beta interferons, the first drugs to be approved for the treatment of relapsing-onset multiple sclerosis.

Top news of the day from across the health care industry.

JB's husband has been noticing out of character behavior. Could it be 1 of her medications?

A novel vaccine to prevent hepatitis C infection has been tested in Baltimore and at two other sites in the United States.

The prescription of stimulants for the treatment of attention deficit-hyperactivity disorder (ADHD) is increasing among adolescents and young adults, and a new study sheds light on possible safety concerns.

Measles, although highly contagious, can be prevented altogether through widespread vaccination.

Interim phase 3 trial results showed an increased risk of death for patients receiving venetoclax for multiple myeloma.

Although there have been links between esophageal cancer and drinking hot tea, this was the first study to examine a specific temperature.

A phase 3 study compared overall survival and cardiac safety between biosimilar trastuzumab (Ontruzant) and the reference medicine.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care industry.

Patients with multiple sclerosis who consumed 2 cans of soda per day were 5 times more likely to experience severe disability.

Solriamfetol (Sunosi, Jazz Pharmaceuticals) is the first dual-acting dopamine and norepinephrine reuptake inhibitor approved for this indication.

The impact has been a continual struggle for pharmacies to provide adequate and appropriate patient care.

You have a passion for helping people feel better, live longer, and enjoy life more. But, is your current place of employment allowing you to do that?

Mrs. Winslow's Soothing Syrup, created in 1849, contained morphine and alcohol and was recommended in high doses.

When combined, treatment with metformin and heme suppressed tumor growth in mice.

A pilot study suggests compounds found in coffee may slow the growth of prostate cancer.

Top news of the day from across the health care industry.

Officials with the FDA have approved brexanolone (Zulresso, Sage Therapeutics) injection for intravenous use for the treatment of postpartum depression in adult women.

Higher body mass index at beginning of menstruation linked to greater risk of developing multiple sclerosis.

With patient pay responsibility expected to climb 50% of every health care dollar by 2020, solutions to streamlining reimbursement may help.

Lawsuit alleges that patients paid artificially high prices for brand-name Humira, and that they were deprived of the benefits of early, robust competition from biosimilars as a result of wrongful conduct.